
Disorders Associated with Multiple Deletions of Mitochondrial DNA
Author(s) -
Haltia Matti,
Suomalainen Anu,
Majander Anna,
Somer Hannu
Publication year - 1992
Publication title -
brain pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.986
H-Index - 132
eISSN - 1750-3639
pISSN - 1015-6305
DOI - 10.1111/j.1750-3639.1992.tb00681.x
Subject(s) - mitochondrial dna , biology , genetics , chronic progressive external ophthalmoplegia , gene , mitochondrial disease , southern blot , muscle biopsy , mitochondrial myopathy , nuclear gene , genome , mitochondrion , microbiology and biotechnology , pathology , biopsy , medicine
Multiple deletions of mitochondrial DNA (mtDNA) have recently been described in a number of patients with neurological disorders. Most cases have been clinically characterized by autosomal dominant inheritance, adult onset, and a slowly progressive course with external ophthalmoplegia and muscle weakness. Some patients have had evidence of central or peripheral nervous system involvement or episodes of myoglobinuria. Muscle biopsy findings include ragged‐red fibres (RRF), muscle fibres with absent COX‐activity and abundant abnormal mitochondria with paracrystalline inclusions. Biochemically, a generalized reduction in the activities of mtDNA‐encoded enzymes is observed in skeletal muscle. Southern blotting or PCR analysis reveal multiple populations of deleted mtDNA. The deletions occur at multiple sites between the replication initiation sites, involving a large portion of mtDNA, and most deletions seem to be flanked by direct sequence repeats, shown to be “hot spots” in the case of single large deletions. Apparently, a defect in a nuclear gene results in multiple deletions of mtDNA. Both clinical, genetic and molecular genetic observations indicate heterogeneity of this new disease category, apparently based on a disturbance in the “cross‐talk” between the nuclear and the mitochondrial genomes.